We are live on
!
Find out more
GP
Geneva Partners Portfolio holdings
AUM
$208M
1-Year Est. Return
72.91%
This Fund
S&P 500
This Quarter
Est. Return
-6.84%
1 Year Est. Return
+72.91%
3 Year Est. Return
+251.81%
5 Year Est. Return
+429.32%
10 Year Est. Return
–
AUM
$102M
AUM Growth
-$60.1M
(-37%)
Cap. Flow
-$54M
Cap. Flow
% of AUM
-53.04%
Top 10 Holdings %
Top 10 Hldgs %
46.54%
Holding
80
New
6
Increased
8
Reduced
37
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$4.92M |
| 2 |
Alibaba
BABA
|
+$3.36M |
| 3 |
AstraZeneca
AZN
|
+$3.22M |
| 4 |
Philip Morris
PM
|
+$1.95M |
| 5 |
IBDQ
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
|
+$1.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$7.92M |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$5.71M |
| 3 |
Williams Companies
WMB
|
+$4.98M |
| 4 |
CVS Health
CVS
|
+$4.45M |
| 5 |
Deere & Co
DE
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 21.26% |
| 2 | Healthcare | 16.9% |
| 3 | Technology | 10.69% |
| 4 | Consumer Staples | 9.97% |
| 5 | Industrials | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Lockheed Martin
LMT
$131B
| $5.58M | 5.48% |
12,975
-105
| -0.8% | -$46.1K |
|
2
Chevron
CVX
$382B
| $5.51M | 5.42% |
38,085
-4,677
| -11% | -$773K |
|
3
Elevance Health
ELV
$81.5B
| $5.14M | 5.06% |
10,662
-1,187
| -10% | -$587K |
|
|
4
IBM
IBM
$213B
| $5.14M | 5.06% |
+36,437
| New | +$4.92M |
|
5
PepsiCo
PEP
$196B
| $5.07M | 4.98% |
30,424
-164
| -0.5% | -$27.6K |
|
6
Microsoft
MSFT
$2.9T
| $4.77M | 4.69% |
18,577
-3,737
| -17% | -$1.01M |
|
|
7
Williams Companies
WMB
$85.8B
| $4.47M | 4.39% |
143
-144,168
| -100% | -$4.98M |
|
8
iShares Core S&P 500 ETF
IVV
$858B
| $4.24M | 4.16% |
11,171
-717
| -6% | -$295K |
|
|
9
Alibaba
BABA
$276B
| $3.9M | 3.83% |
+34,305
| New | +$3.36M |
|
10
Alphabet (Google) Class A
GOOGL
$4.12T
| $3.52M | 3.46% |
32,300
-25,860
| -44% | -$3.04M |
|
11
Oneok
OKE
$56.7B
| $3.49M | 3.43% |
62,919
-4,208
| -6% | -$273K |
|
12
UnitedHealth
UNH
$382B
| $3.47M | 3.41% |
6,748
-849
| -11% | -$426K |
|
13
Fidelity Dividend ETF for Rising Rates
FDRR
$730M
| $3.25M | 3.2% |
84,246
-3,229
| -4% | -$134K |
|
|
14
AstraZeneca
AZN
$269B
| $3.24M | 3.19% |
+24,523
| New | +$3.22M |
|
15
Vanguard High Dividend Yield ETF
VYM
$80.8B
| $3.05M | 3% |
29,967
-29,571
| -50% | -$3.2M |
|
16
BlackRock Municipal 2030 Target Term Trust
BTT
$1.44B
| $2.77M | 2.72% |
124,859
+3,978
| +3% | +$90K |
|
|
17
Philip Morris
PM
$309B
| $2.47M | 2.43% |
24,992
+19,082
| +323% | +$1.95M |
|
18
Chubb
CB
$140B
| $2.28M | 2.24% |
11,576
-515
| -4% | -$106K |
|
19
Thermo Fisher Scientific
TMO
$214B
| $2.18M | 2.14% |
4,011
-222
| -5% | -$122K |
|
20
iShares MSCI USA Quality Factor ETF
QUAL
$45.7B
| $2.13M | 2.09% |
19,036
-1,411
| -7% | -$172K |
|
21
Monster Beverage
MNST
$95.1B
| $2.11M | 2.08% |
45,562
+5,082
| +13% | +$221K |
|
22
Abbott
ABT
$188B
| $1.92M | 1.89% |
17,680
-27,688
| -61% | -$3.14M |
|
|
IBDQ
23
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $1.77M | 1.74% |
+71,581
| New | +$1.78M |
|
24
ExxonMobil
XOM
$650B
| $1.77M | 1.74% |
20,640
+4,970
| +32% | +$448K |
|
25
State Street SPDR S&P 500 ETF Trust
SPY
$771B
| $1.73M | 1.7% |
4,574
-196
| -4% | -$80.3K |
|
Similar funds
SWM
BWM
EPG
MCP
EM
MIM
MIP
FHWM
Geneva Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Geneva Partners held 80 positions worth $102M, down 37% from $162M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Geneva Partners withdrew a net $54M in Q2 2022, closing 27 positions and reducing 37 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $7.92M position sold in full.
By sector, the portfolio is most concentrated in Energy at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Geneva Partners opened a new position in IBM worth $5.14M.
- Geneva Partners's largest Q2 2022 buy was IBM: 36,437 shares worth $5.14M.
- Geneva Partners added most to Philip Morris in Q2 2022, an estimated $1.95M increase.
- Geneva Partners's biggest Q2 2022 reduction was Williams Companies, cutting an estimated $4.98M.
- Geneva Partners fully exited Berkshire Hathaway Class B in Q2 2022, selling an estimated $7.92M.
- Geneva Partners's ten largest holdings make up 47% of its $102M portfolio in Q2 2022.
- Geneva Partners opened 6 new positions and closed 27 in Q2 2022.
- Geneva Partners's portfolio value fell 37% quarter-over-quarter to $102M.
Based on Geneva Partners's 13F filing for Q2 2022, filed 25 Jul 2022.